Nachrichten zur Regeneron Pharmaceuticals Inc. Aktie

XETR : MARKET_RESET for Partition ID [56] - RGO Product ID [586419]

Market Reset. Product ID: [586419](US75886F1075) Product State: HALT Last msg key: 16854824046667781511...…

Regeneron (REGN) Posts Upbeat Data From Multiple Myeloma Study

A mid-stage study data shows that treatment with Regenerons (REGN) experimental antibody achieved a 71% objective response rate in heavily…

The Zacks Analyst Blog Highlights AbbVie, Intel, Qualcomm, Regeneron and CME Group

AbbVie, Intel, Qualcomm, Regeneron and CME Group are included in this Analyst Blog....…

Sanofi:Dupixent Phase 3 COPD Results Presented At ATS & Published In New England Journal Of Medicine

PARIS (dpa-AFX) - Sanofi and Regeneron Pharmaceuticals Inc. (REGN) presented positive Phase 3 results evaluating the investigational use of Dupixent…

Regeneron (REGN) Faces Challenges as Eylea Sales Decline

Regeneron (REGN) loses some of its gains as sales of its lead drug, Eylea, decline. Nevertheless, Dupixent sales boost the…

U.S. Supreme Court Rules Against Amgen In Cholesterol Drug Patent Dispute With Sanofi

THOUSAND OAKS (dpa-AFX) - The U.S. Supreme Court ruled against Amgen (AMGN) in a long-running patent battle with Sanofi (SNY)…

Regeneron Announces Investor Conference Presentations

TARRYTOWN, N.Y., May 18, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as…

Regeneron Says Supreme Court Ruling Ends Patent Dispute With Amgen

Regeneron Says Supreme Court Ruling Ends Patent Dispute With Amgen...…

Supreme Court rules against Amgen in Repatha patent dispute with Sanofi/ Regeneron

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron CEO supports FTC suit against Amgen acquisition of Horizon - FT

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron (REGN) Q1 Earnings & Sales Top, Eylea Sales Decline

Regeneron (REGN) beats earnings and sales estimates in first-quarter 2023 fueled by Dupixent. However, sales of the lead drug Eylea…

Why Regeneron Pharmaceuticals Stock Is Tanking Today

Investors are worried about Eyleas falling sales....…

Regeneron tops Q1 estimates but lowers margin guidance, sending stock lower

Regeneron Pharmaceuticals Inc. ‘s stock REGN slid 4% premarket Thursday, after the company topped estimates for first-quarter earnings but …

Form 8-K REGENERON PHARMACEUTICAL For: May 04

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 10-Q REGENERON PHARMACEUTICAL For: Mar 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron Pharmaceuticals Q1 Profit Decreases, but beats estimates

WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals (REGN) announced earnings for first quarter that decreased from the same period last year but…

Regeneron Posts Higher 1Q Sales, Boosted by Sanofi Work

Regeneron Posts Higher 1Q Sales, Boosted by Sanofi Work...…

Regeneron beats quarterly profit estimates on Dupixent strength

...(Reuters) -Regeneron Pharmaceuticals Inc beat Wall Street estimates......…

Regeneron beats quarterly profit estimates on Eylea strength

...May 4 (Reuters) - Regeneron Pharmaceuticals Inc beat Wall Street......…

Regeneron Reports First Quarter 2023 Financial and Operating Results

TARRYTOWN, N.Y., May 04, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial results for…

Regeneron looks to strong Dupixent, Eylea sales in Q1 report

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Earnings Season Could Be Great for Regeneron (REGN)

Regeneron (REGN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season....…

Alnylam und Regeneron melden positive klinische Zwischenergebnisse der Phase 1 zu ALN-APP, einem RNAi-Prüftherapeutikum für Alzheimer-Krankheit und zerebrale Amyloidangiopathie

CAMBRIDGE, Massachusetts, und TARRYTOWN, New York--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) und Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) meldeten heute positive…

Insiderhandel: Aufsichtsrat verkauft Aktien von Regeneron Pharmaceuticals im Wert von 2.451.149$

Brown, Michael S. - Aufsichtsrat - Tag der Transaktion: 2023-04-21...…

Regeneron (REGN) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Regeneron (REGN) closed at $800.73, marking a +0.33% move from the previous day....…

Regeneron Pharmaceuticals Chairman P. Roy Vagelos to Retire

Regeneron Pharmaceuticals Chairman P. Roy Vagelos to Retire...…

Regeneron Announces Retirement of Board Chair, Dr. P. Roy Vagelos, Accomplished Physician-Businessman and Industry Luminary

Dr. Leonard S. Schleifer and Dr. George D. Yancopoulos to become Co-Chairs of the Board and Christine A. Poon to…

Regeneron Pharmaceuticals: Kursziel gekürzt

New York (www.aktiencheck.de) - Rating-Update: Das Anlagevotum der Analysten von Morgan Stanley für die Aktie von Regeneron Pharmaceuticals (ISIN: US75886F1075,…

Regeneron Announces Investor Conference Presentations

TARRYTOWN, N.Y., April 11, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as…

Regeneron Pharmaceuticals Q1 one-off charges to be ~$56M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K REGENERON PHARMACEUTICAL For: Apr 10

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Will Regeneron (REGN) Beat Estimates Again in Its Next Earnings Report?

Regeneron (REGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

Insiderhandel: Aufsichtsrat verkauft Aktien von Regeneron Pharmaceuticals im Wert von 81.931$

Ryan, Arthur F. - Aufsichtsrat - Tag der Transaktion: 2023-04-03...…

Insiderhandel: EVP Commercial verkauft Aktien von Regeneron Pharmaceuticals im Wert von 900.680$

Mccourt, Marion - Vorstand - Tag der Transaktion: 2023-04-03...…

Regeneron to Report First Quarter 2023 Financial and Operating Results and Host Conference Call and Webcast on May 4, 2023

TARRYTOWN, N.Y., April 03, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will…

Regeneron (REGN) Gains But Lags Market: What You Should Know

Regeneron (REGN) closed at $821.67 in the latest trading session, marking a +1.25% move from the prior day....…

Regeneron Pharmaceuticals: Kurszielanhebung

New York (www.aktiencheck.de) - Rating-Update: Akash Tewari, Analyst von Jefferies & Co, stuft die Aktie von Regeneron Pharmaceuticals (ISIN: US75886F1075,…

Regeneron in research agreement with Xeris Biopharma

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Is This Pharma Duo on the Brink of Another Billion-Dollar Opportunity?

Sanofi and Regenerons top-selling drug could soon be approved to treat yet another disease....…

Regeneron Pharmaceuticals: "buy"

Wien (www.aktiencheck.de) - Rating-Update: Hans Engel, Analyst von Erste Group Research, nimmt die Coverage für die Aktie von Regeneron Pharmaceuticals Inc.…

Insiderhandel: EVP Finance CFO verkauft Aktien von Regeneron Pharmaceuticals im Wert von 150.372$

Landry, Robert E. - Vorstand - Tag der Transaktion: 2023-03-27...…

Insiderhandel: EVP Finance CFO verkauft Aktien von Regeneron Pharmaceuticals im Wert von 829.234$

Landry, Robert E. - Vorstand - Tag der Transaktion: 2023-03-28...…

Form 8-K REGENERON PHARMACEUTICAL For: Mar 27

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron Libtayo gets expanded approval in EU for lung cancer subtype

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron Pharmaceuticals: Kursziel angehoben

San Francisco (www.aktiencheck.de) - Rating-Update: Mohit Bansal, Analyst von Wells Fargo Advisors, stuft die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075,…

Regeneron to pay Sonoma $75M upfront in pact to develop autoimmune disease drugs

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron Pharmaceuticals: Kursziel erhöht

Milwaukee (www.aktiencheck.de) - Rating-Update: Die Analysten von Robert W. Baird stufen die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075, WKN: 881535,…

Regeneron Partners With Sonoma Biotherapeutics To Develop T Cell Therapies

WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals, Inc. (REGN) and Sonoma Biotherapeutics, Inc. Tuesday announced partnership to discover, develop and sell T…

Regeneron and Sonoma Biotherapeutics Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases

Sonoma Biotherapeutics to receive $75 million upfront, inclusive of $45 million cash and $30 million equity investment; potential for an…

Regeneron Pharmaceuticals: Kurszielerhöhung

London (www.aktiencheck.de) - Rating-Update: Carter Gould, Analyst von Barclays, bestätigt das Rating "overweight" für die Aktie von Regeneron Pharmaceuticals Inc. (ISIN:…